MedPath

Myotonia and Muscle Stiffness in NMD

Completed
Conditions
Neuromuscular Disorders
Registration Number
NCT04411732
Lead Sponsor
LMU Klinikum
Brief Summary

The primary objective of this study is to assess stiffness, muscle tone, relaxation periods and elasticity of various muscles in patients with dystrophic or non-dystrophic myotonia. The secondary objectives are (1) to provide reference values for stiffness, muscle tone, relaxation periods and elasticity of various muscles in patients with dystrophic or non-dystrophic myotonia; to provide reference values for stiffness, muscle tone, relaxation periods and elasticity of various muscles in patients with non-myotonic neuromuscular disorders, (3) assess correlations between to compare result values for stiffness, muscle tone, relaxation periods and elasticity with clinical muscle function tests, measured by clinical evaluation (MRC-scale) and the 6-minute walk test; (4) assess correlations between subcutaneous fat and muscle thickness and echogenicity, measured by muscle ultrasound and result values for stiffness, muscle tone, relaxation periods and elasticity.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
133
Inclusion Criteria

For Patients:

  • ≥18 years of age
  • Confirmed neuromuscular disease
  • written consent
  • able and willing to perform study prodcedures

For healthy volunteers:

  • age ≥18 years of age
  • written informed consent
  • no clinical sign for neuromuscular disorders
Exclusion Criteria
  • Severe comorbidities
  • Patient is participating in another clinical study using investigational treatment
  • Patient cannot perform required muscle function tests
  • the patient, in the opinion of the investigator, is unable to adhere to the requirements of the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
MyotonPro device in patients with dystrophic and non-dystrophic myotonia1 day

The primary objective of this study is the comparison of viscoelastic stiffness of the underlying tissue measured by stiffness (S), elasticity (D) and relaxation (R) between patients with dystrophic and non-dystrophic myotonia.

Secondary Outcome Measures
NameTimeMethod
MyotonPro device - reference values in patients with non-myotonic neuromuscular disorders1 day

The secondary objective of this study is to provide reference values for stiffness, muscle tone, relaxation periods and elasticity of various muscles in patients with non-myotonic neuromuscular disorders.

MyotonPro device - correlations between stiffness, muscle tone, relaxation periods and elasticity and the 6-minute-walk test1 day

The secondary objective of this study is to compare stiffness, muscle tone, relaxation periods and elasticity with clinical muscle endurance function tests, measured by the 6-minute walk test.

MyotonPro device - correlations between stiffness, muscle tone, relaxation periods and elasticity with subcutaneous fat and muscle thickness and echogenicity1 day

The secondary objective of this study is to assess correlations between subcutaneous fat and muscle thickness and echogenicity, measured by muscle ultrasound and result values for stiffness, muscle tone, relaxation periods and elasticity.

MyotonPro device - reference values in patients with dystrophic and non-dystrophic myotonia1 day

The secondary objective of this study is to provide reference values for stiffness, muscle tone, relaxation periods and elasticity of various muscles in patients with dystrophic or non-dystrophic myotonia.

MyotonPro device - correlations between stiffness, muscle tone, relaxation periods and elasticity with clinical muscle function tests1 day

The secondary objective of this study is to compare stiffness, muscle tone, relaxation periods and elasticity with clinical muscle function tests, measured by clinical evaluation (MRC-scale).

Trial Locations

Locations (1)

Friedrich-Baur-Institute, Dep. of Neurology Klinikum der Universitaet Muenchen

🇩🇪

Munich, Bavaria, Germany

Friedrich-Baur-Institute, Dep. of Neurology Klinikum der Universitaet Muenchen
🇩🇪Munich, Bavaria, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.